Search
-
The Viviane Tabar Lab
… Berlin C, Lange K, Lekaye HC, Hopland K, Phillips S, Piao J, Tabar V . Long-term clinically relevant rodent model of methotrexate-induced cognitive impairment. Neuro Oncol. 2020 April 2; 22(8): 1126-1137 PMCID: PMC7594568. Dincer Z, Piao J, Niu L, Ganat Y, Kriks S, Zimmer B, Shi S, Tabar V , Studer
-
Find out how MSK uses radiation therapy to shrink or kill liver tumor cells.
… Radiation therapy can shrink or kill tumor cells. At Memorial Sloan Kettering, we may recommend this approach if you have a primary liver tumor that can’t be removed with surgery. It can be used alone or in combination with chemotherapy or other treatments. Both image-guided radiation therapy and respiratory
-
Department of Surgery
The fellowship is structured to provide a two year experience in research and clinical training. The fellowship is the largest and oldest of its kind in the world.
… VIDEO | 01:45 Training at MSK See what it's like to train at Memorial Sloan Kettering, a world-renowned academic medical center dedicated to patient care, research, and education. Video Details As one of the preeminent cancer care institutions in the world, Memorial Sloan Kettering Cancer Center (MSK
-
Technology Development
… SK2010-069 Description The Caov-3 cell line is a primary ovarian cancer cell line with epithelial morphology. These cells form tightly packed colonies in adherent culture. All-trans retinoic acid has been shown to suppress the growth of Caov-3 ovarian carcinoma cells in vitro . These cells express the
-
Patient & Caregiver Education
This information explains brachytherapy for ocular (eye) tumors, including how to get ready and what to expect during and after your treatment.
… This information explains brachytherapy for ocular (eye) tumors, including how to get ready and what to expect during and after your treatment. About ocular brachytherapy Figure 1. Figure 1. Ocular brachytherapy plaque Brachytherapy is a type of radiation therapy. With brachytherapy, radioactive seeds
-
Patient & Caregiver Education
En esta información se explica qué es la braquirradioterapia destinada a tratar los tumores oculares (del ojo), en particular cómo prepararse para el tratamiento y qué esperar durante y después de su tratamiento.
… En esta información se explica qué es la braquirradioterapia destinada a tratar los tumores oculares (del ojo), en particular cómo prepararse para el tratamiento y qué esperar durante y después de su tratamiento. Acerca de la braquirradioterapia ocular Figura 1. Figura 1. Placa de braquirradioterapia
-
Patient & Caregiver Education
Эта информация поможет вам понять, что такое брахитерапия глазных опухолей, как к ней подготовиться и чего ожидать во время и после проведения терапии.
… Эта информация поможет вам понять, что такое брахитерапия глазных опухолей, как к ней подготовиться и чего ожидать во время и после проведения терапии. Информация об офтальмологической брахитерапии Рисунок 1. Рисунок 1. Аппликатор для офтальмологической брахитерапии. Брахитерапия — это один из видов
-
Patient & Caregiver Education
本信息对眼部肿瘤的近距离放射治疗进行介绍,包括如何准备以及治疗期间和治疗后预期会发生的情况。
… 本信息对眼部肿瘤的近距离放射治疗进行介绍,包括如何准备以及治疗期间和治疗后预期会发生的情况。 眼部近距离放射治疗相关信息 图 1. 图 1. 眼部近距离放射治疗金片 近距离放射治疗是放射疗法的一种。 在近距离放射治疗中,会将放射性粒子放置在肿瘤内部或附近。 这意味着肿瘤会受到大量的辐射,而附近的健康组织受到的辐射较少,受损的可能性也较小。 进行眼部近距离放射治疗时,会通过手术在您的眼睛表面放置一个带有放射性粒子的金片(薄金片)(见图 1)。 金片可以保护您的身体其他部位免受粒子的辐射。 在金片放置在您眼睛上期间,您会一直接受近距离放射治疗。 通常会持续 2 到 4 天。 在近距离放射治疗期间,您需要留在医院接受放射隔离
-
Learn how we use the latest techniques and state-of-the-art equipment to identify even the most uncommon forms of lymphoma.
… At Memorial Sloan Kettering, we use the latest techniques and state-of-the-art equipment to identify and characterize even the most uncommon forms of lymphoma. Before you start any treatment, we’ll want to be sure that we have a clear and complete understanding of what exactly is making you sick. To
-
News
Scientists have generated a compound that could potentially be used to create a new type of pain medication that may prevent the side effects of currently available painkillers.
… Tuesday, December 13, 2011 Summary Scientists have generated a compound that could potentially be used to create a new type of pain medication that may prevent the side effects of currently available painkillers. A Memorial Sloan Kettering study suggests that in the future, researchers might be able